WEI-SHIUNG YANG2021-07-022021-07-0220190929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072613634&doi=10.1016%2fj.jfma.2019.09.004&partnerID=40&md5=48d1a58714fb0ba29e68590814aa7a50https://scholars.lib.ntu.edu.tw/handle/123456789/567525[SDGs]SDG3acetylsalicylic acid; antihypertensive agent; lipid; statin (protein); blood pressure; body composition; cerebrovascular accident; cost effectiveness analysis; diabetes mellitus; diabetic nephropathy; Editorial; health care personnel; health care policy; health care quality; human; lifestyle; prevalence; revascularization; Taiwan; diabetes mellitus; diabetic complication; economics; forecasting; hospitalization; Diabetes Complications; Diabetes Mellitus; Forecasting; Hospitalization; Humans; TaiwanEditorial10.1016/j.jfma.2019.09.004315643862-s2.0-85072613634